Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human B-cell lines constitutively express and secrete interleukin-16.

V Sharma1, J L Sparks, J D Vail

  • 1Laboratory of Cytokine Research, Department of Biology, University of West Florida, Pensacola, FL 32514, USA.

Immunology
|February 26, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Invasive aspergillosis involving multiple paranasal sinuses--a case report.

Indian journal of medical microbiology·2005
Same author

Endogeneous endophthalmitis caused by Sporobolomyces salmonicolor.

Eye (London, England)·2005
Same author

Measurements of branching fractions and time-dependent CP-violating asymmetries in B --> eta'K decays.

Physical review letters·2005
Same author

Search for decays of B0-->e+ e-, B0-->mu+ mu-, B0-->e +/- mu-/+.

Physical review letters·2005
Same author

Branching fraction and CP asymmetries of B0-->K0(S)K0(S)K0(S).

Physical review letters·2005
Same author

Search for lepton flavor violation in the decay tau+/- --> mu+ gamma.

Physical review letters·2005
Same journal

Epidermal Dominance of Metabolically Constrained Immune Niches Underpins Immune Activation Signatures and Clinical Severity in Psoriatic Disease.

Immunology·2026
Same journal

Thymic APC Networks Orchestrate T-Cell Selection: Mechanisms and Therapeutic Opportunities in Immune Disorders.

Immunology·2026
Same journal

Immune Checkpoints in Leukaemia as Gatekeepers of Immuno-Modulation.

Immunology·2026
Same journal

Senescent Human Liver Endothelial Cells Mediate CD4<sup>+</sup> T Cell Recruitment via ICOSL.

Immunology·2026
Same journal

The Transcription Factor EGR2 Plays a Central Role in the Expansion and Function of TCRαβ<sup>+</sup>CD4<sup>-</sup>CD8<sup>-</sup> Double Negative T Cells in lpr Lupus Mice.

Immunology·2026
Same journal

Epigenetic Gene Networks Governing Immune State Transitions Across the Lifespan.

Immunology·2026
See all related articles

Human B cells express and secrete Interleukin-16 (IL-16), a protein known to inhibit human immunodeficiency virus-1 (HIV-1) replication. This finding opens new avenues for understanding HIV-1 pathogenesis and potential therapeutic strategies.

Area of Science:

  • Immunology
  • Virology
  • Cell Biology

Background:

  • Interleukin-16 (IL-16) is produced by CD8+ T lymphocytes and inhibits HIV-1 replication.
  • The role of IL-16 in B cells, particularly in the context of HIV-1 infection, remains largely unexplored.

Purpose of the Study:

  • To investigate the expression and secretion of IL-16 in human B-cell lines.
  • To determine if B cells contribute to the body's defense against HIV-1 through IL-16 production.

Main Methods:

  • Utilized reverse transcription-polymerase chain reaction (RT-PCR) to detect IL-16 mRNA.
  • Analyzed a panel of B-cell lines from patients with and without AIDS-associated B-cell lymphomas (AABCL).
  • Conducted kinetic studies to determine optimal expression and secretion timelines.

Related Experiment Videos

Main Results:

  • Ubiquitous expression of IL-16 mRNA was observed across all tested human B-cell lines.
  • IL-16 secretion by human B-cell lines was demonstrated for the first time.
  • Optimal IL-16 expression and secretion were found to occur at approximately 24 hours.

Conclusions:

  • Human B cells constitutively express IL-16 mRNA and secrete the protein.
  • These findings suggest a novel role for B cells in antiviral immunity against HIV-1.
  • B-cell-derived IL-16 may represent a new therapeutic target or biomarker in HIV-1 infection.